In infants with an isolated elevated γ‑glutamyl transferase, what are the likely causes and recommended diagnostic work‑up?

Isolated Elevated γ-Glutamyl Transferase in Infants

In infants with isolated elevated GGT, the most critical first step is to measure conjugated bilirubin—if >25 μmol/L, urgent pediatric referral is essential to rule out serious cholestatic liver disease including biliary atresia, progressive familial intrahepatic cholestasis (PFIC), and Alagille syndrome. 1

Understanding the Clinical Context

Isolated GGT elevation in infants requires careful interpretation because GGT levels are physiologically higher in early infancy and influenced by feeding method. Breastfed infants have significantly higher GGT levels (median 79-101 IU/L) compared to formula-fed infants (46.5-64 IU/L) in the first months of life, with levels progressively declining over time 2, 3. This physiological variation must be distinguished from pathological elevation.

Diagnostic Framework

Immediate Assessment

• Measure conjugated (direct) bilirubin: This is the single most important test. Conjugated bilirubin >25 μmol/L mandates urgent pediatric/hepatology referral 1
• Assess stool and urine color: Acholic (pale) stools or dark urine suggest biliary obstruction
• Measure ALT and AST: Helps distinguish cholestatic from hepatocellular patterns
• Document feeding history: Breastfeeding status affects interpretation of GGT levels 2, 3

Pattern Recognition: High-GGT vs Low-GGT Cholestasis

The GGT level helps categorize cholestatic disorders into two distinct groups 4:

High-GGT cholestasis (when bilirubin is also elevated) suggests:

• Biliary atresia (most common cause of neonatal cholestasis, ~50% of cases) 5
• Alagille syndrome (JAG1/NOTCH2 mutations)
• Ciliopathies
• Mitochondrial hepatopathies
• Alpha-1 antitrypsin deficiency (7-18% of neonatal cholestasis cases) 5

Low/normal-GGT cholestasis indicates:

• PFIC types 1 & 2 (ATP8B1, ABCB11 mutations)
• Bile acid synthesis disorders (BASDs)
• Tight junction protein defects (TJP2)
• Metabolic disorders (galactosemia, tyrosinemia)

Specific Diagnostic Work-Up

For isolated GGT elevation with normal bilirubin:

1. Retest in 2-4 weeks with complete liver panel including:

   • GGT, ALT, AST, conjugated/unconjugated bilirubin
   • Alkaline phosphatase
   • Albumin, PT/INR (synthetic function)
   • Creatine kinase (to exclude myopathy) 6

2. If GGT remains elevated, proceed with:

   • Alpha-1 antitrypsin level and phenotype (not just level alone, as it's an acute phase reactant) 5, 7, 8
   • Abdominal ultrasound to assess biliary tree, gallbladder, liver architecture
   • Consider genetic testing for KIF12 mutations (emerging cause of elevated GGT hepatopathy) 9

For elevated GGT with conjugated hyperbilirubinemia:

1. Urgent additional tests:

   • GGT/AST ratio: >2 has 80.9% sensitivity for biliary atresia 10
   • GGT/ALT ratio: >2 has 83.1% sensitivity for biliary atresia 10
   • Total bile acids: Normal levels (0-10 μmol/L) with low-GGT cholestasis suggest BASDs 4
   • Plasma lactate: Markedly elevated (>5 mmol/L) suggests mitochondrial hepatopathy 4
   • Ferritin: Extremely high (>2000 μg/L) suggests gestational alloimmune liver disease (GALD) or hemophagocytic lymphohistiocytosis 4
   • Alpha-fetoprotein: Markedly elevated (>20,000 ng/mL) suggests mitochondrial disease, tyrosinemia, or GALD 4

2. Imaging:

   • Hepatobiliary scintigraphy (HIDA scan) if biliary atresia suspected
   • Abdominal ultrasound with attention to gallbladder (absent/abnormal suggests biliary atresia)

3. Genetic testing:

   • JAG1/NOTCH2 for Alagille syndrome (if dysmorphic features, cardiac murmur, butterfly vertebrae) 7, 11
   • SERPINA1 for alpha-1 antitrypsin deficiency
   • Cholestasis gene panel (ABCB11, ATP8B1, ABCB4, etc.) 7

4. Metabolic screening:

   • Urine organic acids (tyrosinemia)
   • Galactose-1-phosphate uridyltransferase (GALT) activity for galactosemia 12
   • Plasma amino acids
   • Acylcarnitine profile

5. Check for hypoglycemia: If present with preserved synthetic function, suggests metabolic or endocrine disorder 4

Critical Pitfalls to Avoid

• Do not dismiss elevated GGT as physiological without measuring conjugated bilirubin 1
• Do not rely on alpha-1 antitrypsin level alone—must obtain phenotype, as levels rise during acute illness 7
• Do not delay referral if conjugated bilirubin >25 μmol/L—biliary atresia outcomes are time-dependent (Kasai procedure ideally <60 days of life) 10
• Heterozygous alpha-1 antitrypsin deficiency (PiMZ) is not always benign—may present with isolated GGT elevation and warrants surveillance 8
• Liver biopsy has limited diagnostic utility in Alagille syndrome and should not delay genetic testing 11

When to Refer

Immediate pediatric gastroenterology/hepatology referral if:

• Conjugated bilirubin >25 μmol/L 1
• Acholic stools or dark urine
• GGT/AST or GGT/ALT ratio >2 10
• Hepatosplenomegaly, ascites, or coagulopathy
• Persistent elevation beyond 3 months despite normal bilirubin

Routine referral if:

• Isolated GGT elevation persists >3-6 months
• Family history of liver disease
• Associated failure to thrive or developmental concerns